Aspire Private Capital, LLC Abbott Laboratories Transaction History

Aspire Private Capital, LLC

$398 Million
Q4 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$109.52 - $120.96 $1,533 - $1,693	-14 Reduced 9.59%	132 $15,000
Q4 2023 Feb 01, 2024	BUY	$90.19 - $110.4 $1,352 - $1,656	15 Added 11.45%	146 $16,000
Q3 2023 Nov 03, 2023	SELL	$95.53 - $114.62 $1,815 - $2,177	-19 Reduced 12.67%	131 $12,000
Q2 2023 Jul 24, 2023	SELL	$100.78 - $112.29 $1,108 - $1,235	-11 Reduced 6.83%	150 $16,000
Q1 2023 May 30, 2023	SELL	$96.86 - $114.01 $523,818 - $616,566	-5,408 Reduced 97.11%	161 $16,000
Q1 2023 May 03, 2023	SELL	$96.86 - $114.01 $523,818 - $616,566	-5,408 Reduced 97.11%	161 $16,000
Q4 2022 May 30, 2023	BUY	$95.06 - $111.52 $514,084 - $603,100	5,408 Added 3359.01%	5,569 $611,000
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $36,598 - $42,935	385 Added 7.43%	5,569 $611,000
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $17,707 - $20,501	183 Added 3.66%	5,184 $502,000
Q2 2022 Aug 01, 2022	SELL	$102.07 - $123.37 $19,903 - $24,057	-195 Reduced 3.75%	5,001 $543,000
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $80,954 - $98,718	710 Added 15.83%	5,196 $615,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $15,596 - $19,097	135 Added 3.1%	4,486 $631,000
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $19,248 - $21,294	165 Added 3.94%	4,351 $514,000
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $122,610 - $144,330	1,159 Added 38.29%	4,186 $485,000
Q1 2021 May 26, 2021	BUY	$108.84 - $128.23 $192,973 - $227,351	1,773 Added 141.39%	3,027 $363,000
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $2,835 - $3,089	27 Added 2.2%	1,254 $137,000
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $23,459 - $28,490	256 Added 26.36%	1,227 $134,000
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $74,349 - $95,158	971 New	971 $89,000
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $6,533 - $9,553	-104 Closed	0 $0
Q4 2018 Feb 25, 2019	BUY	$65.56 - $74.27 $6,162 - $6,981	94 Added 940.0%	104 $8,000
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $655 - $742	10 New	10 $8,000

Others Institutions Holding ABT

# of Institutions

3,361

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

Vanguard Group Inc Valley Forge, PA

169M
Shares

$22.8 Billion
0.34% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$17.7 Billion
0.31% of portfolio
State Street Corp Boston, MA

77.2M
Shares

$10.4 Billion
0.35% of portfolio
Capital International Investors Los Angeles, CA

68M
Shares

$9.17 Billion
1.51% of portfolio
Capital Research Global Investors Los Angeles, CA

54.1M
Shares

$7.3 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspire Private Capital, LLC with notifications on news.

Account